Posted November 18, 2011 by M. Miller
The F.D.A. is revoking its approval of the drug Avastin for breast cancer. This comes after concluding that it “has not been shown to be safe and effective for that use.”
Roche, the maker of Avastin, states it will remain an approved treatment for certain other types of cancer.
Current breast cancer patients have pleaded desperately for the approval to be retained, as they feel the treatment is keeping them alive.
September 13, 2013 Louisiana Association for Justice Fall Conference Topic: Persuading the 21st Century Jury At the Windsor Court Hotel New Orleans, […]
By Andrea Schmauss August 20, 2013 – In June 2013, at the 40th Anniversary the Denton Cooley, MD Center in Houston, Carolyn […]
By Buck Daniel August 14, 2013 – More than 700 Pradaxa cases have now been filed in the Southern District of Illinois before […]
By Buck Daniel August 14, 2013 – Since our last update, several big developments have occurred in the nationwide Actos litigation. The […]
